Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Dr. Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Dr. Pavitra Dewda, GSK – GlaxoSmithKline, Belgium

Dr. Pavitra Dewda is a seasoned Global Medical Director with over a decade of experience in the pharmaceutical and biotechnology industries, specializing in medical strategy, clinical development, and vaccine lifecycle management. Currently at GlaxoSmithKline, she leads global medical strategies for vaccines, focusing on hepatitis, pertussis, and pneumococcal vaccines. Previously, she held leadership roles at Merck KGaA and Sanofi Pasteur, driving initiatives in medical affairs and scientific engagement. Dr. Dewda has been recognized with multiple global awards for her contributions to vaccine education, regulatory affairs, and medical strategy. 🌍💉💊📈👩‍🔬

 

Publication Profile

Scopus

Education & Professional Development

 

Dr. Pavitra Dewda holds an MD from Padmashree Dr. D.Y. Patil University, Pune (2011), and an MBBS from Maharashtra University of Medical Science (2005). Her strong educational foundation in medicine has enabled her to excel in the global pharmaceutical industry. With a passion for medical strategy and vaccine development, Dr. Dewda continues to enhance her expertise through ongoing professional development in clinical affairs, regulatory management, and public health. Her education forms the bedrock for her impactful career in global medical leadership. 🎓💉📚👩‍⚕️

Executive Career Synopsis & Highlights

Dr. Pavitra Dewda is a seasoned global medical leader, currently serving as Global Medical Director at GlaxoSmithKline (GSK) since December 2022. She leads global medical lifecycle accountability for key vaccine portfolios, including hepatitis and pertussis, and drives strategic partnerships, advocacy, and medical strategy. Previously, she was General Manager Medical at GSK India, where she led medical operations, secured regulatory approvals, and executed successful vaccine launches. Dr. Dewda has also held leadership roles at Sanofi and Merck KGaA, excelling in medical affairs, strategic initiatives, and digital transformation, receiving multiple awards for her innovative contributions. 💉🌍🎓

 

Research Focus

Dr. Pavitra Dewda’s research focuses primarily on vaccinology 🦠💉, infectious diseases 🦠, medical affairs 🩺, and fertility medicine 👶. She has contributed to studies on hepatitis A and B vaccination for at-risk adults in Europe, emphasizing healthcare professionals’ knowledge, attitudes, and practices. Dr. Dewda also co-authored research on vaccinating healthcare providers in India, showcasing the importance of immunization in healthcare settings. Additionally, she has explored fertility treatments 🌱, particularly in in vitro fertilization (IVF) outcomes, demonstrating her expertise in both public health and reproductive health. Her work blends clinical research and medical strategy.

 

Publication Top Notes

  • “Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk Adults” – Vaccines, 2023, 11(11), 1645 🦠💉 | Cited by: 1
  • “A Modern Perspective on Vaccinating Healthcare Service Providers in India: A Narrative Review” – Infectious Diseases and Therapy, 2022, 11(1), 81–99 🩺💉 | Cited by: 5
  • “Association between progesterone elevation on the day of human chronic gonadotropin trigger and pregnancy outcomes after fresh embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cycles” – Frontiers in Endocrinology, 2018, 9(APR), 201 👶⚗️ | Cited by: 23

 

 

Keun Hyung Park | Clinical Research | Best Researcher Award

Published on by Global Academic Awards

Dr. Keun Hyung Park | Clinical Research | Best Researcher Award

Dr. Keun Hyung Park, Sunjin Clinical Research Center (SCRC), Sunjin BeautyScience Co., Ltd., South Korea

Dr. Keun Hyung Park is an accomplished expert in genetic engineering and immunology, with a PhD from Kyung Hee University (2014). He currently serves as the Head of Sunjin Clinical Research Center and is an advisory committee member at Korea Bio Research Center. Dr. Park has published extensively on skin science, wound healing, and inflammation, contributing to top journals like J Immunol and Skin Research & Technology. He is also a recognized voice in the cosmetics industry through his insightful columns on K-beauty trends. 🧬💼💡 His expertise spans molecular biology, clinical research, and dermatological studies.

Publication profile

Scopus

Education 🎓

Dr. Keun Hyung Park holds advanced degrees in Genetic Engineering with a focus on Immunology from Kyung Hee University. He earned his Master’s degree in 2008, gaining a strong foundation in molecular biology and immunology. Continuing his academic journey, he completed his PhD in 2014, further specializing in immunology-related genetic engineering. His extensive education has equipped him with the expertise to contribute significantly to the fields of molecular biology, clinical research, and dermatology, positioning him as a leader in both academic and industry settings. 🧬📚

 

Professional Experience 🧑‍🔬

Dr. Keun Hyung Park is currently the Head of SUNJIN Clinical Research Center, where he serves as Director and Principal Investigator (PI) since 2024. He is also a member of the expert committee for Cosinkorea and an advisory committee member of the Korea Bio Research Center. Previously, he was a lecturer in molecular biology at Kyung Hee University (2012-2013) and led the safety clinical team at IEC Korea (2014-2020). He held key roles in skin clinical consulting, including at THE K BEAUTY SCIENCE and OATC Skin Clinical Trial Center. 🧫🧴

 

Research Focus

Dr. Keun Hyung Park’s research primarily focuses on immunology and inflammation, particularly the molecular mechanisms underlying inflammatory responses and their modulation. His work explores the role of natural compounds in attenuating inflammation and promoting angiogenesis. Dr. Park investigates signaling pathways such as MAPK and NF-κB, contributing to our understanding of how these pathways influence immune cell behavior and tissue healing. Additionally, he examines the effects of various natural extracts on cellular processes, emphasizing their potential therapeutic applications in treating inflammatory diseases and enhancing wound healing. His research has significant implications for developing innovative treatments in biomedicine. 🧬🌿💉

 

Publication Top Notes

  • Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-κB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock (30 citations) – 2015 🐭
  • Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells (28 citations) – 2014 🌱
  • The stimulatory effects of Stewartia koreana extract on the proliferation and migration of fibroblasts and the wound healing activity of the extract in mice (20 citations) – 2014 🩹
  • Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs (33 citations) – 2013 🔬
  • Human lactoferrin suppresses TNF-α-induced intercellular adhesion molecule-1 expression via competition with NF-κB in endothelial cells (31 citations) – 2012 🧬

 

 

Eman Helmy Ahmed Abdelmonaim | Pharmaceutical Sector Award | Women Researcher Award

Published on by Global Academic Awards

Dr. Eman Helmy Ahmed Abdelmonaim | Pharmaceutical Sector Award | Women Researcher Award

Dr. Eman Helmy Ahmed Abdelmonaim, National Research Centre NRC, Egypt

Eman Helmy Ahmed Abdelmonaim is an accomplished Egyptian researcher specializing in polymer science and nanotechnology. With a Ph.D. in Chemistry, she has conducted extensive research and received recognition for her work, including prestigious fellowships and awards. Her expertise spans various fields, from organic chemistry to spectroscopic techniques. Eman has contributed significantly to scientific conferences and publications, showcasing her innovative contributions to the field. With a passion for learning and a resilient attitude, she continues to excel in her endeavors, aiming to make impactful contributions to the scientific community. 🧪🔬

 

Publication Profile

Google Scholar

Education and Qualification 

Eman Helmy pursued her academic journey with dedication, starting from Al-Azhar Language School for her high school education in Nasr City, Egypt. She then obtained her Bachelor of Science degree in Special Chemistry from Al Azhar University, graduating with distinction in 2005. Her passion for organic chemistry led her to pursue further studies, culminating in a Master’s degree in Organic Chemistry from Cairo University in 2014. Her research focus on the preparation and characterization of polymeric nanocomposites earned her acclaim, with her thesis being examined by Prof. Dr. Patricia Heiden from Michigan Technological University, USA. In 2019, she successfully completed her Ph.D. in Chemistry, delving into the preparation of polymeric materials embedded in nano-structured oxides through joint supervision from Ain Shams University, Egypt, and Siegen University, Germany. 📚🎓

 

Research Focus

Eman Helmy Ahmed’s research focus revolves around the synthesis and characterization of advanced nanocomposites for various applications, particularly in dielectric materials and optical waveguide technologies. Her work encompasses the preparation and evaluation of hyperbranched polymers embedded with nanoparticles like montmorillonite clay and phosphosilicate, aiming at enhancing their dielectric and optical properties. Through her investigations, she explores the potential of these materials in fields such as electrical applications, planar optical waveguides, and friction coefficient modulation. Eman’s dedication to advancing nanotechnology contributes significantly to the development of innovative solutions for industrial and scientific challenges. 🔬✨

 

Publication Top Notes 

  1. Preparation and evaluation of hyperbranched p-chloromethyl styrene polymers/ montmorillonite clay nanocomposites as dielectric materials 📝 Cited by: 17, Year: 2015
  2. Phosphosilicate–polyamidoamine hyperbranched polymer–Er3+ nanocomposite toward planar optical waveguide applications 📝 Cited by: 13, Year: 2019
  3. Nanocomposites dendritic polyamidoamine-based chitosan hyperbranched polymer embedded in silica–phosphate for waveguide applications 📝 Cited by: 10, Year: 2021
  4. Influence of dispersing lithium grease by hybrid nano titanium and silicon oxides on friction coefficient 📝 Cited by: 10, Year: 2018
  5. Thermal Effect of Er³⁺ Ions Embedded in Smart Nano-Composite Oxide Material Prepared by Sol-Gel Technique 📝 Cited by: 10, Year: 2017
  6. Synthesis and cytotoxic activities of selenium nanoparticles incorporated nano-chitosan 📝 Cited by: 7, Year: 2024
  7. Influence of adding contaminants particles to lithium grease on the frictional coefficient 📝 Cited by: 6, Year: 2017
  8. Morphological and spectroscopical characterization of hyperbranched polyamidoamine–zwitterionic chitosan‑encapsulated 5‑FU anticancer drug 📝 Cited by: 5, Year: 2020
  9. Physical Properties of Tb3+ and Ho3+ Ions Embedded in Nanocomposites Phospho-Silicate📝 Cited by: 5, Year: 2020
  10. Dielectric behavior of some vinyl polymers/montmorillonite nanocomposites on the way to apply them as semiconducting materials 📝 Cited by: 5, Year: 2013